Has Alessandra Falk, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,845 in general payments to Alessandra Falk, MD across 66 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alessandra Falk, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alessandra Falk, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alessandra Falk, MD

Orthopaedic Surgery · Sugar Land, TXNPI 1720437742

Payments from drug & device makers

$20,845in general payments, 2019–2025

Across 66 payments — averaging $315.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$14K
Stryker$4K
Medinc Of Texas$2K
Alafair Biosciences, Inc.$304
Smith+Nephew$248
Nevro Corp.$130
plus $341 from 4 others

What the payments were for

Grants$10,00048%
Travel & lodging$3,33016%
Food & beverage$3,69518%
Education$3,82118%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	16	$13,851
Stryker	34	$4,292
Medinc Of Texas	7	$1,680
Alafair Biosciences, Inc.	2	$304
Smith+Nephew	2	$248
Nevro Corp.	1	$130
Exactech, Inc.	1	$110
Voom Medical Devices, Inc.	1	$89
MVP Orthopedics Inc	1	$85
Treace Medical Concepts, Inc.	1	$57

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,845 in reported general payments places this provider in the 75th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$98,878

Medicare patients

276

Services billed

2,622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	26	$167
Meloxicam	62	$163
Ondansetron OdtOndansetron	21	$120
Pregabalin	15	$108
Cyclobenzaprine Hcl	19	$106
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	11	$34

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Sugar Land

Stephen BurkhartSan Antonio$185.3M
Kirby HittTemple$9.1M
J Richard EvansonPlano$8.1M
Stefan KreuzerHouston$7M
Robert GrahamAustin$6.3M
Richard JonesDallas$6.3M
Howard HarrisBedford$4.6M
Tiffany HuynhHouston$4.6M
Michael WirthSan Antonio$4.5M
Stephen IncavoHouston$4.3M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →